IDEX Corporation (IEX)
$
183.3
+2.15 (1.17%)
Key metrics
Financial statements
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The financial data pertains to the fiscal year 2024. IDEX Corporation, together with its subsidiaries, reported a substantial revenue of $3,268,800,000.00 reflecting its strong market presence. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, catering to various industries including food, chemicals, and energy. Furthermore, the company reported an income before tax of $639,300,000.00 showcasing its pre-tax profitability. It also recorded an operating income of $677,200,000.00 reflecting its earnings from core operations. The gross profit stands at $1,445,200,000.00 highlighting the company's profitability from these operational activities. The HST segment focuses on precision fluidics and biocompatible medical devices, serving markets such as pharmaceuticals and life sciences. Meanwhile, the FSDP segment provides essential equipment and systems for the fire and rescue industry, as well as for commercial paint dispensing applications. The stock is priced at $179.40 positioning it in the higher-end market. With a mid-range market capitalization of $13,847,233,530.00 the company is a steady performer. The stock has an average trading volume of 571,213.00 indicating moderate liquidity. IDEX Corporation is a key player in the Industrial - Machinery industry, contributing significantly to the overall market landscape. It belongs to the Industrials sector, driving innovation and growth. Through its diverse segments, the company continues to establish a solid foundation for future expansion and resilience in varying market conditions, ensuring its position as a vital contributor to the industries it serves.
Investing in IDEX Corporation (IEX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict IDEX Corporation stock to fluctuate between $176.39 (low) and $242.09 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-04-03, IDEX Corporation's market cap is $13,847,233,530, based on 75,544,100 outstanding shares.
Compared to GE Aerospace, IDEX Corporation has a Lower Market-Cap, indicating a difference in performance.
IDEX Corporation pays dividends. The current dividend yield is 1.28%, with a payout of $0.69 per share.
To buy IDEX Corporation (IEX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for IEX. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
IDEX Corporation's last stock split was 3:2 on 2007-05-22.
Revenue: $3,268,800,000 | EPS: $6.67 | Growth: -15.36%.
Visit https://www.idexcorp.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $246.36 (2024-03-22) | All-time low: $169.92 (2025-04-03).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
IEX benefits from strength in its Fluid & Metering Technologies segment, acquisitions and shareholder-friendly policies. However, rising costs and expenses are concerning.
globenewswire.com
Reference is made to the announcement by IDEX Biometrics ASA on 18 March 2025 regarding the results of the exercise of Warrants A. A total of 17,258 Warrants A were exercised, resulting in an aggregate subscription for 17,258 new shares, each Warrant A having an exercise price of NOK 0.15.
globenewswire.com
IDEX Biometrics ASA (“IDEX” or “Company”) released its preliminary financial statements for 2024 on 27 February 2025. Subsequently, on 11 March 2025, the Company announced its revised business strategy plan. The Company has reviewed its assets and business in view of this strategy. Certain equipment items have been written down and an obsolescence provision has been recognised on inventory, and other, minor adjustments have been made. The total effect for the IDEX Biometrics group on the consolidated result for 2024 and the consolidated net equity as of 31 December 2024 amounted to an increased loss of USD 1.6 million and lower equity by the same amount. This will be reflected in the annual financial statements for 2024 to be issued on 30 April 2025.
globenewswire.com
IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Friday 11 April 2025 at 12.00 CET as an online meeting. Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding the loan financing of NOK 30 million secured, proposed debt conversion, and amendment of Convertible Bond.
globenewswire.com
Issuer name: IDEX Biometrics ASA Ex. date: 11 March 2025 Type of corporate action: Possible subsequent offering (repair issue) This information is published in accordance with the requirements of the Continuing Obligations.
globenewswire.com
Oslo, 11 March 2025 Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 11 March 2025 regarding irrevocable undertakings from certain existing shareholders for a total loan amount of NOK 30 million (“Loans”), and a possible subsequent offering, raising up to NOK 6 million, at the same subscription price as in the debt conversion related to the Loans (the "Subsequent Offering"), subject to approval by an Extraordinary General Meeting to be held on or about 11 April 2025. Date on which the terms and conditions of the subsequent offering/repair offering were announced: 11 March 2025; Last day including right: 10 March 2025; Ex-date: 11 March 2025; Record date: 12 March 2025; Date of approval: Expected to be on or about 11 April 2025 by resolution of an Extraordinary General Meeting (to be called); Maximum number of new shares: 600,000,000; and Subscription price: NOK 0.01.
globenewswire.com
Oslo, 11 March 2025 NOTE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
globenewswire.com
Oslo, Norway, 11 March 2025 Following the lack of revenues and low number of revenue-generating agreements secured in Q4 2024, the board of directors (“Board”) of IDEX Biometrics ASA ("IDEX") has undertaken a strategic review, following which the Board has concluded on a new strategy, with a fundamental shift in how IDEX will take its technology and products to market. The review has concluded that IDEX has unique competitive advantages in its biometric Access technology (IDEX Access) and is optimally positioned to offer customers and new and existing channel partners a complete and ready to go product line.
zacks.com
IEX gains from strength across its Fluid & Metering segment, acquired businesses and shareholder-friendly policies. However, rising operating expenses are concerning.
globenewswire.com
Oslo, Norway - IDEX Biometrics has received a production order from the manufacturing partner Beautiful Card Corporation (BCC). The order has a value of approx. USD 50,000 and is the first of a larger biometric payment card program issued across both Mastercard and Visa for the Japanese market.
See all news